ESMO 2022 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ESMO 2022 Conference Coverage

Breast
Lung
GI
GU
Head and Neck
GYN
Sarcoma
Hematology

Playback speed

10 seconds

Lecture Summary - ESMO 2022 on the OS Results From the Phase 3 TROPiCS-02 Study: Sacituzumab Govitecan vs. Treatment of Physician’s Choice in Patients With HR+/HER2- mBC

By ESMO 2022 Conference Coverage FEATURING Hope Rugo

17 views

September 21, 2022

Comments 0

Breast

ESMO 2022 Updates on mTNBC

ESMO 2022 Conference Coverage

L. Carey

1.5K views

ESMO 2022 on the First Results From the BELLINI Trial: Nivo & Ipi in…

ESMO 2022 Conference Coverage

M. Kok

45 views

Lecture Summary - ESMO 2022 on PROs From the Randomized Phase 3 Stud…

ESMO 2022 Conference Coverage

N. Ueno

28 views

ESMO 2022 on DESTINY-Breast04 Patient-Reported Outcomes: T-DXd vs. T…

ESMO 2022 Conference Coverage

N. Ueno

480 views

Lecture Summary - ESMO 2022 on the Biomarker Analyses From Patients …

ESMO 2022 Conference Coverage

F. Mosele

25 views

ESMO 2022 on the Biomarker Analyses From Patients From the DAISY Tri…

ESMO 2022 Conference Coverage

F. Mosele

272 views

Lecture Summary - ESMO 2022 on Primary Endpoint Results of the Rando…

ESMO 2022 Conference Coverage

L. Buisseret

18 views

ESMO 2022 on Primary Endpoint Results of the Randomized Phase 2 SYNE…

ESMO 2022 Conference Coverage

L. Buisseret

82 views

ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates

ESMO 2022 Conference Coverage

H. Rugo, J. O'Shaughnessy

5.9K views

Lecture Summary - ESMO 2022 on the OS Results From the Phase 3 TROPi…

ESMO 2022 Conference Coverage

H. Rugo

17 views

ESMO 2022 on the OS Results From the Phase 3 TROPiCS-02 Study: Sacit…

ESMO 2022 Conference Coverage

H. Rugo

496 views

Lecture Summary - ESMO 2022 on HER2-Low Inflammatory Breast Cancer: …

ESMO 2022 Conference Coverage

P. Tarantino

12 views

ESMO 2022 on HER2-Low Inflammatory Breast Cancer: Clinicopathologic …

ESMO 2022 Conference Coverage

P. Tarantino

424 views

Lecture Summary - ESMO 2022 on a Randomized Phase II METEORA-II Tria…

ESMO 2022 Conference Coverage

E. Munzone

59 views

ESMO 2022 on a Randomized Phase II METEORA-II Trial: Metronomic Oral…

ESMO 2022 Conference Coverage

E. Munzone

161 views

ESMO 2022 on Adjuvant Endocrine Therapy for BC: Who Needs More Than …

ESMO 2022 Conference Coverage

E. de Azambuja

2.5K views

Lecture Summary - ESMO 2022 on the DAISY Trial: Antitumor Activity o…

ESMO 2022 Conference Coverage

N. Epaillard

20 views

ESMO 2022 on the DAISY Trial: Antitumor Activity of T-DXd in Patient…

ESMO 2022 Conference Coverage

N. Epaillard

1.3K views